Last reviewed · How we verify

NCT06880653: DREAM

Dose Response of Exercise for Arthritis Management

Recruiting now NA Last updated 3 April 2026
What this trial tests

NA trial testing DREAM Adaptive Intervention in Arthritis in 285 participants. Currently enrolling.

Timeline
28 March 2025
Primary endpoint
1 October 2028
30 April 2029

Quick facts

Lead sponsorUniversity of South Carolina
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment285
Start date28 March 2025
Primary completion1 October 2028
Estimated completion30 April 2029
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of South Carolina

Who can join

18 and older, any sex, with Arthritis or Rheumatoid Arthritis (RA). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study is to see examine the effects of 3 different levels of physical activity (45 minutes/week, 90 minutes/week, or 150 minutes/week) on arthritis symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arthritis

Currently open trials in the same condition.

Other University of South Carolina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06880653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing